A Year in Review and perspectives for 2023 with Antonio Parada, CEO
Corporate Updates, Flow Eighteen38, News FJB, News IONTAS
Read
Flow Eighteen38 receives €5 million EUR (c.$5.58 million USD) to expand production and biophysical capabilities
Flow Eighteen38, News FJB
Read
Year in Review and 2022 updates with António Parada, CEO
Corporate Updates, Flow Eighteen38, News FJB, News IONTAS
Read
Hubrecht Institute licenses Flow Eighteen38 reagent antibodies for cancer research
Flow Eighteen38, Press Release
Read